N/A
Manufactured by Padagis Israel Pharmaceuticals Ltd
4,560 FDA adverse event reports analyzed
Last updated: 2026-04-15
AMMONIUM LACTATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Padagis Israel Pharmaceuticals Ltd. The most commonly reported adverse reactions for AMMONIUM LACTATE include PAIN, FATIGUE, CHRONIC KIDNEY DISEASE, DIARRHOEA, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMMONIUM LACTATE.
Out of 1,934 classified reports for AMMONIUM LACTATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 4,560 FDA FAERS reports that mention AMMONIUM LACTATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include PAIN, FATIGUE, CHRONIC KIDNEY DISEASE, DIARRHOEA, DRUG INEFFECTIVE, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Padagis Israel Pharmaceuticals Ltd in connection with AMMONIUM LACTATE. Always verify the specific product and NDC with your pharmacist.